Home/iQure Pharma/Prof. Iris Loew-Friedrich, MD
PI

Prof. Iris Loew-Friedrich, MD

Clinical and R&D Advisor

iQure Pharma

iQure Pharma Pipeline

DrugIndicationPhase
iQ-007Treatment-Resistant EpilepsyPhase 1
Preclinical ProgramsNeurodegeneration (e.g., Alzheimer's, Parkinson's) and PainPreclinical